Ricky Zipp is an Editor at Morning Consult. He specializes in medicine and healthcare, focusing on medical technology, healthcare technology, and cybersecurity, with a particular interest in medical equipment innovations. Ricky's work has been featured in prominent publications including BioPharma Dive, Healthcare Dive, Manufacturing Dive, Med Tech News, and Yahoo Finance.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Ricky Zipp's coverage focuses predominantly on the healthcare and pharmaceutical industries, with a strong emphasis on data-driven reporting. He frequently cites data and government announcements, indicating an interest in statistics-backed insights and official releases.
Given his focus on the U.S., pitches should be tailored to provide expert analysis or commentary specific to the national healthcare landscape, medical device industry, pharmaceutical sector, public opinion related to health matters or COVID-19 within the country. Additionally, offering perspectives from reputable professionals with relevant expertise in these areas could increase chances of successful outreach.
As Ricky often covers press releases and government announcements related to healthcare topics such as medical devices and pharmaceuticals within the U.S., providing unique insights into these developments may enhance engagement with him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ricky Zipp
The company said an intruder accessed employee information, customer contact details and other records.
Ricky Zipp 1 min read
The medtech company has been working to restore manufacturing, ordering and shipping operations since it was hit by a cyberattack on March 11.
The company disclosed that it expects a material impact on first-quarter financial results. However, it does not expect an effect on full-year results.
Johnson & Johnson’s strategic shift to higher growth medical device markets like cardiovascular is paying off, as the business was the only medtech unit to grow by double digits in the first quarter.
CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including electrophysiology and Watchman.
The medtech company does not expect any material impact on its business or financial results, according to a filing with the Securities and Exchange Commission.
CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year guidance.
CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year guidance.
Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.
